Healthcare -
Biotechnology - NASDAQ - US
$ 0.8465
3.31 %
$ 306 M
Market Cap
-1.14
P/E
LXRX - REVENUE
Revenue LXRX - Lexicon Pharmaceuticals, Inc.
1.2 M
LAST VALUE
101.00%
2 YEAR CAGR
-54.71%
5 YEAR CAGR
-5.94%
10 YEAR CAGR